REPORT ID 4378

Global Transdermal Drug Delivery System Market Research Report 2017

Publish Date
18-Dec-17
Pages
113
Format
Electronic (PDF)

In this report, the global Transdermal Drug Delivery System market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Transdermal Drug Delivery System in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Transdermal Drug Delivery System market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Novartis AG
    Johnson & Johnson
    Mylan Pharmaceuticals, Inc
    Boehringer Ingelheim GmbH
    Biogel Technology, Inc.
    Transdermal Technologies, Inc.
    Skyepharma PLC
    Watson Pharmaceuticals, Inc
    3M Company
    Noven Pharmaceuticals, Inc
    4P Therapeutics, LLC
    Echo Therapeutics, Inc
    Transdermal Corp
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Electroporation
    Radiofrequency
    Iontophoresis
    Microporation
    Other
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Central Nervous System (CNS)
    Pain Management
    Cardiovascular
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Transdermal Drug Delivery System Market Research Report 2017
1 Transdermal Drug Delivery System Market Overview
    1.1 Product Overview and Scope of Transdermal Drug Delivery System
    1.2 Transdermal Drug Delivery System Segment by Type (Product Category)
        1.2.1 Global Transdermal Drug Delivery System Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Transdermal Drug Delivery System Production Market Share by Type (Product Category) in 2016
        1.2.3 Electroporation
        1.2.4 Radiofrequency
        1.2.5 Iontophoresis
        1.2.6 Microporation
        1.2.7 Other
    1.3 Global Transdermal Drug Delivery System Segment by Application
        1.3.1 Transdermal Drug Delivery System Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Central Nervous System (CNS)
        1.3.3 Pain Management
        1.3.4 Cardiovascular
        1.3.5 Other
    1.4 Global Transdermal Drug Delivery System Market by Region (2012-2022)
        1.4.1 Global Transdermal Drug Delivery System Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Transdermal Drug Delivery System (2012-2022)
        1.5.1 Global Transdermal Drug Delivery System Revenue Status and Outlook (2012-2022)
        1.5.2 Global Transdermal Drug Delivery System Capacity, Production Status and Outlook (2012-2022)

2 Global Transdermal Drug Delivery System Market Competition by Manufacturers
    2.1 Global Transdermal Drug Delivery System Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Transdermal Drug Delivery System Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Transdermal Drug Delivery System Production and Share by Manufacturers (2012-2017)
    2.2 Global Transdermal Drug Delivery System Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Transdermal Drug Delivery System Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Transdermal Drug Delivery System Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Transdermal Drug Delivery System Market Competitive Situation and Trends
        2.5.1 Transdermal Drug Delivery System Market Concentration Rate
        2.5.2 Transdermal Drug Delivery System Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Transdermal Drug Delivery System Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Transdermal Drug Delivery System Capacity and Market Share by Region (2012-2017)
    3.2 Global Transdermal Drug Delivery System Production and Market Share by Region (2012-2017)
    3.3 Global Transdermal Drug Delivery System Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Transdermal Drug Delivery System Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Transdermal Drug Delivery System Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Transdermal Drug Delivery System Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Transdermal Drug Delivery System Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Transdermal Drug Delivery System Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Transdermal Drug Delivery System Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Transdermal Drug Delivery System Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Transdermal Drug Delivery System Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Transdermal Drug Delivery System Consumption by Region (2012-2017)
    4.2 North America Transdermal Drug Delivery System Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Transdermal Drug Delivery System Production, Consumption, Export, Import (2012-2017)
    4.4 China Transdermal Drug Delivery System Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Transdermal Drug Delivery System Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Transdermal Drug Delivery System Production, Consumption, Export, Import (2012-2017)
    4.7 India Transdermal Drug Delivery System Production, Consumption, Export, Import (2012-2017)

5 Global Transdermal Drug Delivery System Production, Revenue (Value), Price Trend by Type
    5.1 Global Transdermal Drug Delivery System Production and Market Share by Type (2012-2017)
    5.2 Global Transdermal Drug Delivery System Revenue and Market Share by Type (2012-2017)
    5.3 Global Transdermal Drug Delivery System Price by Type (2012-2017)
    5.4 Global Transdermal Drug Delivery System Production Growth by Type (2012-2017)

6 Global Transdermal Drug Delivery System Market Analysis by Application
    6.1 Global Transdermal Drug Delivery System Consumption and Market Share by Application (2012-2017)
    6.2 Global Transdermal Drug Delivery System Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Transdermal Drug Delivery System Manufacturers Profiles/Analysis
    7.1 Novartis AG
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Transdermal Drug Delivery System Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Novartis AG Transdermal Drug Delivery System Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Johnson & Johnson
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Transdermal Drug Delivery System Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Johnson & Johnson Transdermal Drug Delivery System Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Mylan Pharmaceuticals, Inc
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Transdermal Drug Delivery System Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Mylan Pharmaceuticals, Inc Transdermal Drug Delivery System Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Boehringer Ingelheim GmbH
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Transdermal Drug Delivery System Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Boehringer Ingelheim GmbH Transdermal Drug Delivery System Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Biogel Technology, Inc.
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Transdermal Drug Delivery System Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Biogel Technology, Inc. Transdermal Drug Delivery System Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Transdermal Technologies, Inc.
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Transdermal Drug Delivery System Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Transdermal Technologies, Inc. Transdermal Drug Delivery System Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Skyepharma PLC
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Transdermal Drug Delivery System Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Skyepharma PLC Transdermal Drug Delivery System Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Watson Pharmaceuticals, Inc
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Transdermal Drug Delivery System Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Watson Pharmaceuticals, Inc Transdermal Drug Delivery System Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 3M Company
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Transdermal Drug Delivery System Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 3M Company Transdermal Drug Delivery System Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Noven Pharmaceuticals, Inc
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Transdermal Drug Delivery System Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Noven Pharmaceuticals, Inc Transdermal Drug Delivery System Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 4P Therapeutics, LLC
    7.12 Echo Therapeutics, Inc
    7.13 Transdermal Corp

8 Transdermal Drug Delivery System Manufacturing Cost Analysis
    8.1 Transdermal Drug Delivery System Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Transdermal Drug Delivery System

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Transdermal Drug Delivery System Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Transdermal Drug Delivery System Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Transdermal Drug Delivery System Market Forecast (2017-2022)
    12.1 Global Transdermal Drug Delivery System Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Transdermal Drug Delivery System Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Transdermal Drug Delivery System Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Transdermal Drug Delivery System Price and Trend Forecast (2017-2022)
    12.2 Global Transdermal Drug Delivery System Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Transdermal Drug Delivery System Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Transdermal Drug Delivery System Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Transdermal Drug Delivery System Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Transdermal Drug Delivery System Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Transdermal Drug Delivery System Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Transdermal Drug Delivery System Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Transdermal Drug Delivery System Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Transdermal Drug Delivery System Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer